Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics.

Oncotarget · 2014 · PMC4039123 · PMID 24722433

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

INPROGAS: An INflammatory PROtein-driven GAstric cancer Signature When the 21 proteins with highly significant differences in expression between GC and non-GC tissues were assigned into categories based on Gene Ontology (GO) Consortium-defined molecular function , more than one-third (36%) of the proteins demonstrated cytokine/chemokine activity.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.